Sandra Ortega-Martorell
Overview
Explore the profile of Sandra Ortega-Martorell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lythgoe C, Hamilton D, Johnston B, Ortega-Martorell S, Olier I, Welters I
J Intensive Care Soc
. 2025 Feb;
:17511437251315319.
PMID: 39911517
Background: Community acquired pneumonia (CAP) is a common cause of hospital admission. CAP carries significant risk of adverse outcomes including organ dysfunction, intensive care unit (ICU) admission and death. Earlier...
2.
Liu Y, Chen Y, Olier I, Ortega-Martorell S, Huang B, Ishiguchi H, et al.
Eur J Clin Invest
. 2024 Dec;
55(3):e14371.
PMID: 39660499
Background: Although oral anticoagulation decreases the risk of thromboembolism in patients with atrial fibrillation (AF), a residual risk of thrombotic events still exists. This study aimed to construct machine learning...
3.
Ortega-Martorell S, Olier I, Ohlsson M, Lip G
Trends Cardiovasc Med
. 2024 Dec;
PMID: 39653093
Atrial fibrillation (AF) is a complex condition caused by various underlying pathophysiological disorders and is the most common heart arrhythmia worldwide, affecting 2 % of the European population. This prevalence...
4.
Ortega-Martorell S, van Kempen E, Jouvent E, Tuladhar A
Thromb Haemost
. 2024 Nov;
PMID: 39613147
No abstract available.
5.
Ortega-Martorell S, Olier I, Lip G
Eur Heart J
. 2024 Nov;
46(3):229-232.
PMID: 39565293
No abstract available.
6.
Ortega-Martorell S, Olier I, Ohlsson M, Lip G
Thromb Haemost
. 2024 Oct;
125(1):7-11.
PMID: 39401519
No abstract available.
7.
Bellfield R, Olier I, Lotto R, Jones I, Dawson E, Li G, et al.
EBioMedicine
. 2024 Aug;
107:105280.
PMID: 39153412
Background: Atrial fibrillation (AF) is the most common heart arrhythmia worldwide and is linked to a higher risk of mortality and morbidity. To predict AF and AF-related complications, clinical risk...
8.
Bellfield R, Ortega-Martorell S, Lip G, Oxborough D, Olier I
J Electrocardiol
. 2024 Mar;
84:17-26.
PMID: 38471239
Background We aim to determine which electrocardiogram (ECG) data format is optimal for ML modelling, in the context of myocardial infarction prediction. We will also address the auxiliary objective of...
9.
Wang R, Liu Y, Thabane L, Olier I, Li L, Ortega-Martorell S, et al.
Nutr J
. 2024 Feb;
23(1):15.
PMID: 38302934
Background: The association between dietary iron intake and the risk of type 2 diabetes mellitus (T2DM) remains inconsistent. In this study, we aimed to investigate the relationship between trajectories of...
10.
Ungan G, Pons-Escoda A, Ulinic D, Arus C, Ortega-Martorell S, Olier I, et al.
NMR Biomed
. 2024 Jan;
37(4):e5095.
PMID: 38213096
The standard treatment in glioblastoma includes maximal safe resection followed by concomitant radiotherapy plus chemotherapy and adjuvant temozolomide. The first follow-up study to evaluate treatment response is performed 1 month...